Stratasys has launched its TrueDent-D resin in Europe, marketing the product as a CE Mark Class I medical device. TrueDent monolithic multi-shade digital denture solution in European countries that require CE marking.

Following its successful U.S. debut in 2023, the monolithic multi-shade digital dental solution is now set to deliver a scalable, efficient, and high-quality solution for denture production for European dental labs and clinicians.

According to a recent iData report,¹ European demand for denture solutions continues to grow, with the region’s overall opportunity for dentures projected to expand from $2.19 billion in 2023 to $2.45 billion by 2028. The TrueDent denture solution by Stratasys is designed to answer this demand with a fully digital workflow that enables dental labs to produce customized dentures efficiently, offering dentists and patients an improved outcome in fewer appointments.

Stratasys estimates the total cost for a lab to produce a TrueDent denture is less than half of those produced by traditional means. One Stratasys J5 DentaJet printer can produce more than 30 full monolithic, multi-shade dentures per print job, a figure unmatched in the industry, according to the company.

A key feature is the ability to print a duplicate denture with a click of a button, enabling clinicians to quickly provide a spare or a backup for their patients. TrueDent reportedly is the only solution on the market that can produce identical dentures when needed, offering not just fit, form and function, but also aesthetics. This capability creates potential for new business models, allowing customers to scale production without increasing costs or labor requirements.

“The TrueDent solution has transformed our denture business,” said Tra’ Chambers, owner of Express Dental Laboratories, a U.S. TrueDent customer. “The streamlined digital workflow and precision allows us to produce up to 225 dental appliances per day while delivering high fidelity, highly aesthetic appliances to our customers. The Stratasys TrueDent offering has elevated the level of care we can provide, saving time and costs for both clinicians and patients.”

Edentulism, the condition of being without natural teeth, affects more than 267.5 million people globally, including a prevalence rate exceeding 10% among adults over 50 in many regions. The percentage of denture cases produced using digital methods in the United States has risen from 5% in 2022 to 11% in 2024. Similarly, European dental labs are increasingly adopting digital workflows to address labor shortages and meet patient needs faster and with greater accuracy.

The TrueDent denture solution elevates the challenges faced by labs that are limited by current fabrication methods that often involve the need for manual assembly by skilled craftspeople. By implementing an unattended streamlined digital workflow, TrueDent eliminates 27 or more manual touchpoints per print, reduces chair time for dental professionals and patients, and enhances patient satisfaction with high-aesthetic, true-to-design fit, form and function appliances.

“We are thrilled to bring TrueDent-D to Europe,” Stratasys Healthcare Vice President Erez Ben Zvi stated. “Our monolithic TrueDent denture solution combines high fidelity, aesthetics, and production scalability, while reducing labor costs and enabling exact reproductions. There is growing excitement across the region for this solution, which not only improves the experience for dental professionals but also elevates the standard of care for patients.”

Stratasys develops 3D printing solutions for industries such as aerospace, automotive, consumer products, and healthcare. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain.

Reference
¹ iData Europe Market Report Suite for Dental Prosthetics, February 2024